Voyager Therapeutics, Inc. VYGR
2.68
(0.12)
(4.29%)
as of 25 Sep
- Market cap
- $172.5M
- P/E
- 0.0×
Follow VYGR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 2.79 | 0.00 | 0.00 | 7.30 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
5.71 | 4.09 | 1.55 | 5.67 | 2.74 | 1.55 | 4.80 | 39.56 | 46.63 | 21.30 |
P/FCF ratio |
0.00 | 0.00 | 5.19 | 0.00 | 0.00 | 0.00 | 12.18 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(7.62) | (22.50) | (16.30) | (18.95) | 9.15 | (12.08) | (21.44) | (12.38) | (31.86) | (23.13) |
P/B ratio |
1.18 | 1.09 | 1.64 | 3.93 | 1.08 | 1.72 | 5.03 | 6.49 | 3.53 | 2.23 |
Price to Tangible BV |
1.18 | 1.09 | 1.64 | 3.93 | 1.08 | 1.72 | 5.03 | 6.49 | 3.53 | 2.23 |
EV/Sales |
0.85 | 0.75 | 0.63 | 2.77 | (0.80) | 0.49 | 2.10 | 19.11 | 29.95 | 9.03 |
EV/EBITDA |
0.00 | 0.00 | 1.27 | 0.00 | 0.44 | 2.70 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.26) | (3.94) | 2.01 | (9.05) | 0.56 | (0.87) | 4.51 | (9.17) | (4.95) | (3.02) |
EV/FCF |
(0.25) | (3.20) | 2.09 | (7.55) | 0.55 | (0.78) | 5.33 | (7.21) | (4.65) | (2.70) |
Quick Ratio |
7.47 | 5.40 | 4.87 | 1.64 | 2.61 | 7.07 | 3.95 | 4.93 | 10.73 | 12.80 |
Current Ratio |
7.64 | 5.56 | 4.96 | 1.72 | 2.68 | 7.39 | 4.01 | 5.13 | 10.81 | 12.95 |
Net Debt/EBITDA |
1.50 | 3.08 | (1.88) | 2.66 | 1.95 | (5.80) | 5.36 | 1.71 | 2.41 | 4.36 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.13 | 0.22 | 0.98 | 0.23 | 0.16 | 0.56 | 0.39 | 0.04 | 0.05 | 0.07 |
Operating CF/Net income |
1.11 | 0.24 | 0.59 | 0.27 | 0.75 | (2.63) | (1.12) | 0.18 | 0.87 | 1.06 |
Capex/Depreciation |
(2.39) | 1.09 | (4.00) | (0.40) | (0.29) | (3.15) | 9.21 | 93.59 | (2.54) | (3.84) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (48.29%) | (24.25%) | 89.61% | (60.24%) | (57.10%) | 28.95% | (59.74%) | (97.83%) | (52.37%) | (26.36%) | |
| (37.10%) | (17.47%) | 51.83% | (26.28%) | (31.27%) | 11.92% | (16.40%) | (48.84%) | (37.80%) | (19.18%) | |
ROIC |
0.00% | (157.38%) | 1,400.53% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(63.25%) | (26.93%) | 48.71% | (66.52%) | (66.15%) | 18.70% | (17.68%) | (61.49%) | (42.54%) | (23.25%) |
Average Days of Receivables |
17.29 | 9.95 | 121.89 | 2.29 | 7.14 | 17.09 | 64.67 | 9.63 | 52.29 | 59.11 |
Research and Development Expense of Revenue |
333.57% | 159.21% | 36.87% | 148.54% | 197.21% | 63.55% | 114.70% | 851.88% | 614.31% | 297.11% |
Selling, General and Administrative Expense of Revenue |
92.99% | 44.90% | 14.33% | 75.73% | 99.55% | 20.45% | 34.81% | 443.75% | 194.75% | 93.32% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
36.63% | 18.48% | 4.46% | 22.84% | 30.27% | 8.73% | 14.98% | 206.20% | 91.15% | 44.37% |
Graham Net Nets |
0.64 | 0.56 | 0.53 | 0.10 | 0.37 | 0.34 | 0.10 | 0.11 | 0.26 | 0.41 |
Graham Number |
0.00 | 0.00 | 19.98 | 0.00 | 0.00 | 9.57 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(51.91%) | (19.93%) | 35.89% | (20.10%) | (70.11%) | 13.71% | (9.03%) | (29.36%) | (15.14%) | (13.20%) |
Free Cash Flow Yield |
(58.56%) | (5.76%) | 19.28% | (6.46%) | (53.82%) | (40.99%) | 8.21% | (6.70%) | (13.83%) | (15.69%) |
Revenue per Share |
0.69 | 1.39 | 5.81 | 1.07 | 0.99 | 4.61 | 2.91 | 0.24 | 0.38 | 0.56 |
Operating CF per Share |
(2.26) | (0.27) | 1.81 | (0.33) | (1.42) | (2.60) | 1.36 | (0.50) | (2.29) | (1.68) |
Capex per Share |
(0.04) | (0.06) | (0.08) | (0.06) | (0.04) | (0.33) | (0.21) | (0.13) | (0.15) | (0.20) |
Free Cash Flow per Share |
(2.30) | (0.33) | 1.74 | (0.39) | (1.46) | (2.93) | 1.15 | (0.63) | (2.44) | (1.88) |
Cash per Share |
3.35 | 4.62 | 5.37 | 3.10 | 3.52 | 4.88 | 7.84 | 4.86 | 6.31 | 6.89 |
Shareholders Equity per Share |
3.34 | 5.20 | 5.49 | 1.54 | 2.52 | 4.16 | 2.77 | 1.45 | 5.00 | 5.37 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.34 | 5.20 | 5.49 | 1.54 | 2.52 | 4.16 | 2.77 | 1.45 | 5.00 | 5.37 |
Free Cash Flow |
(135.06) | (18.83) | 74.66 | (15.00) | (55.13) | (108.81) | 41.12 | (20.19) | (65.33) | (47.51) |
Working Capital |
176.15 | 227.02 | 255.18 | 51.91 | 85.72 | 171.00 | 228.65 | 130.81 | 155.89 | 164.98 |
Capital Expenditures |
(2.60) | (3.52) | (3.26) | (2.49) | (1.61) | (12.10) | (7.55) | (4.30) | (3.98) | (5.03) |
Net Current Asset Value |
146.49 | 183.52 | 204.72 | 24.16 | 37.90 | 90.51 | 49.41 | 31.90 | 121.36 | 125.14 |
EV/EBIT |
0.00 | 0.00 | 1.28 | 0.00 | 0.41 | 3.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.04 | 0.01 | 0.06 | 0.04 | 0.07 | 0.07 | 0.57 | 0.39 | 0.35 |
Net Profit Margin |
(296.53%) | (81.25%) | 52.93% | (113.45%) | (190.29%) | 21.47% | (41.76%) | (1,158.79%) | (697.56%) | (282.65%) |
Price to Operating Income |
0.00 | 0.00 | 3.17 | 0.00 | 0.00 | 9.70 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | (0.23) | 0.05 | 0.35 | 0.25 | 0.15 | (0.05) | 0.00 | 0.15 | 0.17 |
Cash ROIC |
(37.09%) | (5.23%) | 13.15% | (17.07%) | (33.15%) | (36.41%) | 8.05% | (14.17%) | (23.63%) | (16.23%) |
Accounts Receivable Turnover |
19.73 | 1.87 | 5.97 | 82.72 | 8.56 | 12.91 | 11.17 | 9.22 | 5.40 | 7.57 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Receivables |
2.05 | 42.84 | 41.87 | 0.49 | 4.37 | 13.25 | 9.35 | 0.83 | 1.88 | 1.88 |
Average Payables |
4.50 | 2.80 | 2.09 | 1.57 | 0.60 | 2.35 | 2.55 | 1.03 | 0.79 | 0.58 |
Average Assets |
322.67 | 372.17 | 255.32 | 176.61 | 227.72 | 308.17 | 265.89 | 180.75 | 187.02 | 209.51 |
Average Common Equity |
247.92 | 268.04 | 147.67 | 77.04 | 124.69 | 126.92 | 72.98 | 90.25 | 134.99 | 152.50 |
Columns are period end dates